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This paper explores medical borderlands where health and enhancement practices are
entangled. It draws on fieldwork carried out in the context of two distinct research
projects in Brazil on plastic surgery and sex hormone therapies. These two therapies
have significant clinical overlap. Both are made available in private and public
healthcare in ways that reveal the class dynamics underlying Brazilian medicine. They
also have an important experimental dimension rooted in Brazil’s regulatory context
and societal expectations placed on medicine as a means for managing women’s
reproductive and sexual health. Off-label and experimental medical use of these
treatments is linked to experimental social use: how women adopt them to respond to
the pressures, anxieties and aspirations of work and intimate life. The paper argues
that these experimental techniques are becoming morally authorized as routine
management of women’s health, integrated into mainstream Ob-Gyn healthcare, and
subtly blurred with practices of cuidar-se (self-care) seen in Brazil as essential for
modern femininity.
Keywords: plastic surgery; hormonal therapies; Brazil; gender and sexuality;
reproductive health
Introduction
Medical enhancement has become an urgent social issue in part because it sometimes 
and a lot depends on how often  works. The athlete takes steroids, at considerable risk,
because they really do enhance performance. And as medical enhancement becomes more
efficacious (however defined), it finds new users: China and Brazil are now respectively
the world’s third and second largest markets for cosmetic surgery, while in many develop-
ing countries ‘prescription’ drugs are used to boost sexual or mental performance (Sanabria
forthcoming). As medical enhancement spreads, it becomes harder to evaluate its health
and ethical implications. While technologies such as genetic engineering have provoked
weighty ethical questions about ‘tampering with nature’ or ‘playing God’ (Parens 1998),
such questions can also distract us from the problems raised by more ordinary forms of
medical self-regulation and self-optimization that occur within routine healthcare.
This paper explores medical borderlands where health and enhancement practices are
subtly entangled. It is based on ethnographic fieldwork in Brazilian cities, carried out in
the context of two distinct research projects: on the uses of plastic surgery in Rio de
Janeiro (Edmonds) and sex hormone therapies in Salvador da Bahia (Sanabria), primarily
by women. During fieldwork we each interviewed healthcare practitioners (mostly
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surgeons, psychologists, endocrinologists, GPs, ObGyns, and nurses), observed clinical
practices, and conducted ethnographic work with patient-consumers that took us into
social contexts not directly tied to medical care.1
Cosmetic surgery and sex hormones are very different kinds of therapies that target
different aspects of the body, health and well-being.2 But in Brazil they have important
areas of clinical overlap as a means of intervening in, or optimizing, women’s reproduc-
tive and sexual health and well-being. Hormonal contraceptives are among the most
widely prescribed drugs in pharmaceutical history. In Brazil, they are widely available
in a range of combinations and modes of delivery. They also have controversial ration-
ales not limited to contraception or treatment of menopausal symptoms, such as regulat-
ing menstruation, body shape, or sexual and social performance. Such off label uses are
often blurred with more acceptable indications such as birth control. We thus use the
local term hormo^nio to include the overlapping indications and experimental uses of
these drugs in Brazil. Globally, the availability of cosmetic surgery is more limited and
is generally considered a form of enhancement. But in Brazil, the full range of proce-
dures  including breast and abdominal surgeries, liposuction and ‘lipoescultura’ (rein-
jecting body fat), nose jobs, and face lifts  have become more widely available in
recent decades, and are often presented as an essential means of managing women’s
reproductive, sexual and psychological health. Following local usage, we refer to cos-
metic surgeries as ‘plastica.’
We bring these two cases together to explore how they have become normalized
within a two-tier healthcare system and used experimentally to manage women’s repro-
ductive and sexual lives. Plastica and hormo^nio are available in both private and public
healthcare in ways that reveal the class dynamics underlying Brazilian medicine. More-
over, both therapies have an important experimental dimension, which we link to Brazil’s
regulatory context and societal expectations placed on medicine as a means for managing
women’s health.
We argue these therapies are sometimes used with the intent of engineering the sexual
and reproductive body from the inside out. We further argue that these therapies are
becoming morally authorized as routine ways of managing women’s health. They are
often merged with cosmetic and hygienic regimes of cuidar-se (self-care) seen as essen-
tial for modern femininity. Pharmacies, beauty parlors, gyms, health food shops, private
medical practices, and pseudo-medical cosmetic services abound in Brazilian cities. The
patients we encountered viewed hormo^nio and plastica as integral parts of ordinary
regimes of cuidar-se that included work-outs and weight-management, having manicures,
hair straightening, cultivating tan lines, or the ‘Brazilian’ body wax. The distinctions
between cosmetic, hygienic, erotic and health practices are thus often blurred  as are the
lines between necessary medical interventions and those with more diffuse rationales of
boosting auto-estima (self-esteem) or managing life’s exigencies.
While experimental uses of hormo^nio and plastica pose risks to health, they also raise
ethical problems that do not readily fit the conceptual frameworks bioethicists have often
used to discuss medical enhancement (see Parens 1998 and Gordijn and Chadwick 2008).
The very ordinariness of contraceptives can mask their more experimental uses in boost-
ing mood, controlling weight or regulating sexual or social life. And while plastica may
seem to be a more obvious case of medical enhancement, its rationale of enhancement is
subtly minimized as it is practiced in public hospitals or integrated with mainstream
healthcare. Some Brazilian doctors and patients view both of these therapies as a means
of everyday self-care, suggesting that they are not always locally considered
‘enhancement’ in the first place. Concerns about ‘tampering with nature’  rooted in
Anthropology & Medicine 203
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liberal political ideas about bodily autonomy  do not always translate well to other ethi-
cal contexts (Edmonds 2010). Brazilian folk and medical ontologies see the body as con-
siderably plastic  amenable to change and improvement (Rohden 2001, Sanabria 2013).
We suggest a different critical approach, one that focuses on both the experimental
medical uses of these therapies as well as what can be called their experimental social
uses. We explore how these technologies are adopted to respond to pressures, anxieties
and aspirations arising out of work and intimate life. These uses often diverge from offi-
cial medical discourse or public health agendas, although they can receive the tacit sup-
port and encouragement of doctors. We discuss, for example, how plastica and hormo^nio
are used for non-medical purposes such as modulating affects or physical strength at
work, opening social doors, emulating Playboy models, boosting desire, or protecting a
marriage  uses that reveal gendered tensions in the medical and social norms of modern
femininity. Plastica and hormo^nio are integrated into a management regime that makes
‘normal’ reproduction (menstruation, birth, breast feeding and menopause) into risky pro-
cesses requiring ‘aesthetic’ as well as sexual management. Aesthetic goals are morally
authorized as health goals while experimental re-tooling is rendered as necessary, routine
or even pleasurable self-care.
How do medical technologies reflect aspirations for social inclusion or mobility? How
do experimental, aesthetic or lifestyle uses of medicine become legitimated and integrated
with more established forms of healthcare? In responding to these questions our goal is to
develop a critical approach to experimental techniques practiced in the ‘borderlands’
between health-oriented medicine and aesthetic, sexual and psychological self-care.
Therapies in search of disease
In Brazil, hormo^nio and plastica now have medical rationales as a means of intervening
in psychological, sexual and reproductive health in ‘normal’ patients (by altering endo-
crinological systems, anatomy, and body-image). Historically, however, there has been
considerable medical and social uncertainty as to the appropriate use of both of these ther-
apies. We briefly trace their origins as experimental technologies and contextualize their
shifting medical indications.
Historian Oudshoorn (1994) calls hormonal therapies ‘drugs looking for diseases.’
Likewise for plastic surgery, the possibility of reasonably safe aesthetic operations pre-
ceded the ‘discovery’ of the disorders they would heal. Both plastica and hormo^nio were
products of medical advances that held out for some pioneers’ enormous therapeutic 
and financial  potential. Both also predated the medical indication they eventually
‘found.’ Sex hormones were first marketed in the late 1950s as treatments for menstrual
disorders; their contraceptive properties were presented as ‘side effects’ to gauge market
acceptability for a controversial new drug (Marks 2001, 5). Today, birth control is the
main approved indication for hormonal contraceptives, although they have a range of off-
label uses including alleviation of menstrual cramps, menstrual suppression, regulating
the cycle, libido regulation, ‘lifestyle’ indications (see Watkins 2012), and in Brazil, con-
troversial ‘aesthetic’ uses such as weight control and improving skin texture and muscle
tone.3 Since their invention, the rationale for the use of sex hormones has been open to
negotiation and subject to controversy.
Contraceptives in Brazil come in a multitude of delivery systems, dosages and modes
of administration (Sanabria, forthcoming). In addition to variations in oral forms (brand-
name, national copies or generics, combined or minipills, second, third or fourth genera-
tion, etc.), sex hormones may be implanted subdermally, absorbed through the skin (via
204 A. Edmonds and E. Sanabria
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transdermal patches or gels), the vagina (via a vaginal ‘ring’) or the uterus (via an intra-
uterine hormone-releasing ‘system’) or injected (monthly or trimesterly). This multiplic-
ity reflects the search for long-acting contraceptive methods for the developing world, in
which Brazilian medical institutions have played a significant role.4
Doctors also have considerable leeway to experiment with new regimens. This is par-
ticularly true for hormonal implants developed in Brazil where standardized, brand-name
implants such as Implanon are rare. The bulk of implants on the market are produced by
farmacias de manipulac¸~ao (compounding pharmacies) in small-scale laboratories5 and
contain combinations of levonongesterel, estradiol, gestrinone, elcometrin and testoster-
one. Although these implants are presented as state-of-the art treatments, their production
is remarkably low-tech and labor-intensive. In one such pharmacy, Sanabria observed lab
technicians manually crafting implants from silicon tubing and vats of imported, pow-
dered hormo^nio. Implants have a range of blurred indications: as long-acting contracep-
tion, to ‘control’ pre-menstrual symptoms or ‘treat’ endometriosis by suppressing
menstruation, and as hormone-replacement for menopausal symptoms. These treatments
are not all clinically trialed, unlike those produced by transnational pharmaceutical corpo-
rations. The only published data come from observational studies of women, many of
them conducted in Brazil, with loose ethical oversight. One woman Sanabria interviewed
in 2013 explained that her gynecologist had asked her to perform clinical exams (at her
own expense), including cardiovascular and cholesterol analyses. Upon finding out online
that her gynecologist had published a study in which she was likely included, she became
outraged by the risks she had been subjected to as  in her words  ‘a guinea pig’ in an
experiment.
In one of the more radical examples of experimentation with sex hormones, travestis
(transsexuals) use over-the-counter contraceptives to feminize their bodies, often in combi-
nation with injected liquid silicone and, more rarely, medical plastica (Sanabria 2013;
Kulick 1998; Edmonds 2010). These techniques ‘soften’ facial structure and change fat dis-
tribution to emulate national erotic ideals. But women also, and in much greater numbers,
use sex hormones in pursuit of sexual and ‘aesthetic’ effects, most notably with testoster-
one (T). Testosterone therapy regularly makes the headlines in Brazil for its benefits during
work-outs or to boost energy, vontade (will/desire), and disposic¸~ao (disposition/desire).
Marketing and health care practitioners present T as a kind of aphrodisiac, although wom-
en’s descriptions of their experiences are more ambivalent. While observing the routine
insertion or removal of hormonal implants in a Bahian clinic, Sanabria noted the commen-
taries exchanged regarding the small clump of hair-growth that appears at the place of
implantation, usually the bunda (‘bum’). The specialized nurse viewed this tiny clump of
abnormally long, thick hair as visual ‘evidence’ that testosterone really works.
Although the doctors whom Sanabria observed prescribing implants usually referred
to testosterone as dar fogo (to give fire, an explicitly sexual metaphor), patients tended to
emphasize wider dispositional changes. Cleonice is in her mid-40s and married to an
architect from the South of Brazil. Sanabria met her in a clinic where she was having her
implants renewed, which she had been using for over a decade. Cleonice had also had
several ‘minor’  in her words  plasticas (to the eyelids, nose, and facelift). ‘Gosto de
me cuidar (I like caring for myself),’ she explained, ‘and hormones help me feel good,
they help the body, the skin. It improves your performance (in English), you have more
disposition.’ While disposition sometimes refers to sexual interest, Cleonice emphasized
that hormo^nio gives her ‘energy to face her day-to-day, with more vontade (will).’
Besides the increased desire it is said to afford, women explained that T gives them
energy to see or perceive differently and to be more operational in a male world. In 2008
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a series of press articles described the increasing use of testosterone implants by Brazilian
women in academias (gyms). Referred to as mulheres chipadas (women with a micro-
chip), these women said that they build more muscle mass, lose subdermal fat more rap-
idly, and optimize their workout with T. One photographer explained to Sanabria that her
gynecologist had added a T rod to give her more tes~ao (sexual desire). She added that,
thanks to T, her camera boxes felt much lighter and she had more energy for her demand-
ing job and for managing her work/life balance.
While they are not endorsed by all users, drug effects are conditioned by patient
expectations (Moerman and Jonas 2002). Given the absence of clinical trials assessing
such experimental uses of contraceptive implants, it is difficult to separate specific ‘drug
effects’ from the larger medical and social contexts that make them efficacious. The sex-
ual effects of hormones subtly mingle with lifestyle and ‘aesthetic effects’ (discussed
below) such as weight loss, diminishing cellulite, firming muscles, and improving skin
texture.
In contrast to the banality of the pill, cosmetic surgery is often considered an excep-
tional  sometimes even a dangerous  treatment. Yet, reconstructive procedures that
today are perceived as medically uncontroversial, such as correction of a cleft palate,
were once labeled ‘cosmetic’ (Gilman 1999). Cosmetic orthodontics is still classified as
‘cosmetic’ but has also become routinized to the point where denying it to a child is con-
sidered  in the US at least  cruel or irresponsible. We argue that cosmetic surgery in
Brazil is moving towards routinization and becoming an integral part of managing pas-
sage through the female lifecycle.
While doctors had previously experimented with cosmetic procedures, it was only the
consolidation of technical skills through the repairing of the shattered faces of First World
War veterans that raised the possibility of effective cosmetic surgery. Yet social and med-
ical attitudes at the time viewed the use of surgery for exclusively aesthetic aims as frivo-
lous (Gilman 1999). Euro-American society caught up to the therapeutic possibilities of
cosmetic surgery in part due to the popularization of psychoanalytic research pointing to
the emotional significance of appearance (Haiken 1997). Brazilian surgeons have success-
fully advanced a radical ‘psychotherapeutic rationale’ for cosmetic surgery, even justify-
ing its provision in public hospitals. The national healthcare system (Sistema unico de
saude or SUS) does not directly authorize cosmetic surgery (with the exception of a few
procedures). However, some public hospitals offer cosmetic surgeries, which like all pub-
lic sector healthcare is free, in order to provide ‘scientific training’ to surgical residents.
Some chief public surgeons have supported this logic by invoking the universal ‘health’
benefits of cosmetic surgery, which they believe should be available to rich and poor alike
(Edmonds 2009, 2010).
Surgical residents from many countries travel to train in Brazil’s plastic surgery
wards, drawn by opportunities for hands-on practice in cosmetic techniques (Edmonds
2011). One European resident said he had performed 96 surgeries during his third year of
residency, of which 90% were cosmetic. Another European resident, surprised to observe
two major aesthetic surgeries being performed simultaneously in the same room,
remarked that Brazilian surgeons are highly skilled and that complication rates are low.6
In fact patients may be more at risk in some private clinics, which unlike public hospitals
do not have life support systems. High demand and the busy schedules of teaching hospi-
tals have contributed, some plastic surgeons boast, to a specifically Brazilian spirit of
“creativity” and “innovation” (Edmonds 2010).
Other surgical techniques were developed in response to Brazil’s mestic¸o population
and beauty norms, according to surgeons whom Edmonds interviewed. Surgeons
206 A. Edmonds and E. Sanabria
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explained that patients with African ancestry have a higher risk of forming thick keloid
scars, but that due to extensive racial mixing ancestry is not always visible in phenotype.
Thus, before deciding whether an aesthetic breast reduction has a good risk-benefit ratio,
a small ‘test’ incision between the patient’s breasts is made to see whether she will
develop such scars. Surgeons also use cosmetic techniques to emulate the ostensibly
‘good’ effects of what they call ‘miscegenation’  such as ‘body contouring’ that redis-
tributes fat from the waist to the hips. But they also say surgery can correct negative
effects attributed to racial mixing, for example by thinning the nose in order to
‘harmonize’ it with the overall appearance of a patient who identifies as branca (white)
or morena (brown). Such experimental ‘aesthetic indications’ are legitimated by the fact
that cosmetic surgeries are performed in public hospitals, or offered as interventions in
women’s reproductive health (Edmonds 2013a).
Patients are often willing to try experimental techniques, combine surgeries, or have
repeated retoques (touch-ups). The injection of industrial-grade liquid silicone (consid-
ered unacceptably risky and now banned) is usually associated with the transformation of
transvestites in Brazil and other countries. However, Brazilian women have also had liq-
uid silicone injected by doctors or have experimented with this practice themselves, some
coming to public hospitals for corrections. Other patients opt for surgery at the prompting
of doctors to correct flaws they had not perceived themselves. Raquel went to a public
hospital for cosmetic breast surgery, but given the long waiting time, chose a nose job
instead, her second preference. Many patients remain uninformed about the risks of com-
plications, which are rarely discussed and often downplayed for both hormonal treatments
and plastica.
Some experimental uses of these therapies occur at the fringes of ‘mainstream’ medi-
cal practice with little medical supervision. With both plastica and hormo^nio we observed
patients actively seeking out practitioners willing to perform interventions they had heard
about in telenovelas or through acquaintances and relatives. Brazilian plastic surgery and
gynecological wards, we observed, are highly social places where information about pro-
cedures, hospitals, and sympathetic doctors are traded boca a boca (word of mouth). We
now explore further how these therapies are situated within women’s healthcare by dis-
cussing the class dynamics in Brazilian medical institutions.
The class biopolitics of plastica and hormo^nio
Post-dictatorship Brazil (1985) has witnessed rapid, often contradictory changes in
healthcare (Biehl 2005). While social movements succeeded in enshrining the right to
healthcare in the 1988 constitution, the middle classes opted out of (public) healthcare
and turned to private sector services accessed through relatively cheap health insurance 
a development Faveret and Oliveira (1989) refer to as ‘excluding universalism.’
Brazil now has a highly differentiated healthcare system split between a public and a
private sector, to which roughly 25% of the population has access. Some private clinics are
shabby but free of the long public sector queues, while top-end institutions have the hall-
marks of luxury and glamour. The equally heterogeneous public sector is often perceived
as offering lower quality care. Although they are often represented as separate, doctors,
patients and protocols travel between the public and private sectors (Sanabria 2010).
Both plastica and hormo^nio are offered in private and public clinics and hence target
users from a wide range of socioeconomic backgrounds. Oral contraceptives have been
widely available in Brazil since the 1970s when the state reversed its pro-natalist position.
But there continue to be important class differences in prescription patterns for hormonal
Anthropology & Medicine 207
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contraceptives. Rose (2007) and Rose and Rabinow (2006) have distinguished between an
older, disciplinary biopolitics and a newer, emergent biopolitics. The older biopolitics is a
mode of governance  which often includes coercive techniques  exercised by sover-
eign states to regulate their populations’ health. The newer form, they argue, is a mode of
‘self-management’ or ‘somatic individuality’ that reflects the rising importance of a poli-
tics of risk and the ‘responsibilization’ of patient-consumers for their own health in
‘advanced, liberal societies.’ In a limited sense, the ‘older’ mode of biopolitics seems to
be at work in Brazil’s public health sector, where hormones are prescribed according to a
logic of population control tied to national development (Sanabria 2010). The regulation
of reproduction is here framed in terms of moral responsibility to the collectivity, with
working class adolescent and young mothers who ‘fail’ to control fertility often shamed
by Ob-Gyns (McCallum 2005, de Zordo 2012).
At first glance, the ‘newer’ self-management mode of biopolitics seems to be more
clearly at work in the use of sex hormones in private practice medicine. Women often use
hormones to manage affect or limit risks to sexual relationships due to partners’ straying
by chemically boosting their desire with T. While in the private sector sex hormones are
framed within a discourse of personal autonomy, freedom and choice, their actual use
reflects differences between provider and client expectations as well as social pressures
and constraints that problematize the notion of ‘self-management’ (Sanabria 2010). Class
dynamics also shape the management of pre-menstrual tension, one of the key indications
for menstrual suppressive contraceptives in Brazil. The addition of testosterone to
implants is presented as enabling desire for busy middle- and upper-class Brazilian
women. Among low-income patients who use methods such as Depo-Provera (also a
menstrual suppressive), rationales have focused more on the possibilities this affords for
work, where menstruation is seen as depleting strength. Across classes, women explained
that they adopted menstrual suppressive treatments to manage their emotional oscilla-
tions, be these cyclical feelings of depression, irritation or anger, which impede domestic
and work relations.
Like hormonal therapies, plastic surgery is practiced in both public and private health-
care in ways that reflect the class dynamics of Brazilian medicine. Once seen as the pre-
serve of the elite, cosmetic surgery has been “democratized,” as one surgeon boasted. In
the private sector the expansion of consumer credit and the taming of inflation brought
surgery within reach of the middle class. Brazilian cities now have some of the highest
concentrations of plastic surgeons in the world. The routinization of cosmetic surgery
among wealthier Brazilians has contributed to a perception that the practice is an integral
part of modern management regimes for women’s health (Edmonds 2013b).
The aspirational aspect of demand for both hormo^nio and plastica is illustrated by the
role that celebrity patients  and celebrity doctors  play in rendering these technologies
socially visible. Artistas (celebrities) use cosmetic surgery to enlarge or lift their breasts
or buttocks or narrow their waists and widen their hips. These uses have also been
adopted by ‘ordinary’ consumers who learn about celebrity plasticas from magazines
such as Playboy or Plastica & Beleza (Plastica & Beauty). Some surgeons complain
about the unrealistic expectations of patients who walk into their office with a photo of an
artista. Many plastica procedures aim at a kind of hyper-feminine ‘perfection’ linked to
celebrity culture and Brazil’s racialized national identity (Edmonds 2010).
Celebrities have played a key role in popularizing hormonal therapies as well. A cover
story on how telenovela actress Carla Regina lost weight explains that her boyfriend,
gynecologist Malcolm Montgomery, gave her tailored hormonal implants.7 Montgomery
is well known as a gynecologist of the ‘stars.’ He explains that he switched ‘Carla’s’
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implants as the previous testosterone combination ‘injected protein into her muscles aug-
menting their volume. The new combination removes excess swelling and thins her sil-
houette.’ Montgomery added that ‘their prime medical function is to control hormonal
fluctuations and reduce menstrual episodes,’ but ‘the specialist’ noted they also have ‘this
interesting aesthetic effect.’
The ‘aesthetic effects’ of hormonal implants have been highlighted in mainstream
news media. Coverage of S€ao Paulo’s Fashion Week 2012, for example, presented hor-
monal implants as Chipes da beleza (beauty chips) used by models to suppress men-
struation, diminish cellulite, and avoid weight-gain. The only problem with the
‘hormonal chip,’ stated model Natalia Zambiasi, is that ‘it makes you tarada (a sex
maniac).’ Footballer Ronaldo’s ex-girlfriend, model Raica Oliveira, explained she used
the implant for eight years for aesthetic aims: ‘[Without it] I need to work out more,
my bum is sagging, when I use the implant it is all firm and hard.’ Another model
pointed out: ‘You “dry-out,” de-swell, lose weight and cellulite, gain muscle, your
body becomes firmer and your skin texture improves. Plus you free yourself of men-
struation!’ Celebrity gynecologists such as Montgomery and Elsimar Coutinho promote
their work through ‘partnerships’ with the fashion industry. One modeling agency is
reported to have given a model an advance payment of R$35008 for a tailored hor-
monal treatment. While the Brazilian Society for Endocrinology and Metabolism and
the Federal Council of Medicine have criticized such aesthetic indications, other medi-
cal societies actively promote implants while private clinics evade efforts at tighter
regulation through legal loopholes.
These uses of plastica and hormonio may seem to represent a ‘new’ biopolitics
described by Rose (2007) oriented towards risk management; however they are not only
a means of working on the self or ‘somatic individuality.’ For one, they point to the
importance of sexual and class aspirations and celebrity culture in Brazilian medicine.
These practices also reveal the gaps between the vast possibilities that private healthcare
affords and its uneven trickling-down into public health services, where care is often pro-
vided as a ‘favor’ or ‘charity’ rather than a ‘right’ (Sanabria 2010; Edmonds 2010). Medi-
cal techniques are thus adopted not only to constitute oneself as a ‘good’ citizen and avoid
health risks; they involve taking risks to emulate sexual and aesthetic practices that are
used by celebrities as routine self-care. Although these therapies are often practiced
below the radar of state biopolitics, they are not therefore ‘individual’ or devoid of social-
ity. Self-management  or in the local idiom, self-care  is frequently about taking care
of relationships in ways that do not fit notions of neoliberal ‘self-management.’ After all,
individualista is a pejorative term. Cuidar-se is not (just) about the self. In the Brazilian
cases we bring together here, it is also about making social relations through work on bod-
ies. We now analyze how these techniques are embedded within shifting gender relations
in Brazil to account for their local uses.
The social dimensions of self-care: managing passage through the female life-course
A striking feature of both plastica and hormo^nio is that they are presented as technical means
to improve one’s quality of life. As the range of traits that can be rectified, modified or
enhanced increases, the link between what can and what should be altered shifts. In his cul-
tural history of testosterone, Hoberman (2005, p. 8) notes that a ‘drug-enhanced fitness’
made possible by the prescription of estrogens or androgens can be experienced as ‘a man-
date to be sexually active even in the absence of desire’. This obligation to be both desirable
and desiring fits with much of what we observed in our respective field sites.
Anthropology & Medicine 209
D
ow
nl
oa
de
d 
by
 [T
he
 U
niv
ers
ity
 of
 E
din
bu
rg
h]
 at
 08
:15
 03
 Fe
br
ua
ry
 20
15
 
We illustrate this point by analyzing how plastica and hormonal therapies manage
passage through the life-course. The trajectory outlined below is a ‘therapeutic ideal
type,’ not an official clinical recommendation. Doctors and patients choose from among
these therapeutic possibilities, and it would be unlikely for them to all be adopted by one
person. Our aim is to show how women use these techniques to respond to social and
somatic expectations surrounding passage through the life course.
Onset of menses
Some plastic surgeons hesitate to operate on teenagers, who are assumed to be less emo-
tionally stable than adults. However, one surgeon argued that ‘nothing prevents adoles-
cents from seeking a new appearance.’9 Plasticas are in some instances even given to
teenagers for their festa de quinze anos (15th birthday celebrations). One woman Sanabria
interviewed explained the pressure her adolescent daughter felt to ‘maintain appearances’
as her school friends were being ‘bought a pair of breasts’ or a ‘new bum’ by their
parents.
Hormonal contraceptives may be prescribed prior to the onset of regular menstruation,
to delay menarche, manage irregular bleeding (common in early years) or acne. Gynecol-
ogist Coutinho controversially proposed administering Depo-Provera on mass to low-
income teenage girls to limit teen pregnancies. The campaign poster showed an image of
a perfectly toned mestic¸o girl’s belly with bellybutton ring, enticing young girls to opt for
the hormonal methods on offer and keep a nice flat belly instead of acquiring a flaccid,
post-natal one.10
Pregnancy and childbirth
Pregnancy and childbirth are seen to pose risks and cause iatrogenic damage to the female
body, which can be ‘fixed’ through surgical intervention.11 A range of techniques are
available to meet the norm imposed by star culture  as well as medical culture  to rap-
idly return to ‘shape’ post-partum.12 Post-partum plasticas include breast and abdominal
surgeries as well as liposuction and lipoescultura, which redistributes fat in order to
‘contour’ the body’s silhouette. Injunctions to manage weight-gain during pregnancy mix
aesthetic concerns with health risks concerning gestational diabetes or high blood pres-
sure. Plastica is also integrated with mainstream Ob-Gyn, with Ob-Gyns referring moth-
ers to plastic surgeons who promise to return the belly, vagina or breasts to their pre-
pregnancy condition. In Brazil there are high rates not just of cosmetic surgery but also
surgeries such as tubal ligation, episiotomy, hysterectomy and C-section (see Araujo and
Aquino 2003; Giffin et al. 2003; McCallum 2005 and Edmonds 2013a for a discussion of
the links between these surgeries). There are complex causes behind Brazil’s high rate of
C-sections, including physician convenience, but the surgery is sometimes represented as
a legitimate means to avoid damaging the perineum and compromising future sexual
well-being (Carranza 1994; Behague 2002).
However, this goal coexists with decidedly ‘aesthetic’ practices or ones aimed at male
partners. Vaginal births routinely include episiotomies followed by the ponto de marido,
the extra ‘husband’s stitch’ (Diniz and Chacham 2004). In public hospitals Sanabria
(2011) found that some women unable to ‘acquire’ a C-section are given post-partum
vaginal plastica. In the private sector ‘intimate plasticas’ are marketed to increase sexual
pleasure and improve genital appearance. And while C-sections avoid pelvic damage,
they create aesthetic damage to the abdomen  scars and flaccidity  that can be repaired
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with plastica. The routinization of the C-section thus contributes to a new medical ‘need’
for corrective aesthetic surgery (Edmonds 2013a).
Breast feeding
Breastfeeding is widely said to cause aesthetic damage as well as interfere with women’s
sexual desire and availability to their partners. One of the most popular surgeries in Brazil
is breast reduction, which unlike in much of Euro-America, can have a primarily aesthetic
rationale. The surgery is said by surgeons and patients to emulate a national corporeal
ideal  often seen as an Afro-Brazilian legacy  that emphasizes slender waists, full
hips, thighs and buttocks, and relatively small breasts (Hanchard 1999). But breast sur-
gery is also positioned as a means to manage an erotic body threatened by reproduction
(Edmonds 2013b).
Menopause
Hormonal replacement therapy (HRT) is widely prescribed in Brazil for multiple, often
blurred aims: controlling menopausal symptoms, treating sexual dysfunction or boosting
sexual experience. The mainstream news media refers to the inclusion of testosterone in
HRT as the ‘whipped cream of hormonal repositioning.’ Treatments include implants
containing testosterone as well as T-gels, widely available in compounding pharmacies to
be applied topically.
Many Brazilian gynecologists dismiss the health risks of HRT that were shown in
studies by the Women’s Health Initiative (WHI). One private-practice gynecologist who
renewed a HRT prescription for the 12th consecutive year was somewhat naively asked
by the ethnographer about the medical rationale for such lengthy treatment. He angrily
shrugged off the WHI studies as the product of ‘excited North American hairy feminists.’
‘My patients,’ he added, ‘aren’t concerned about future risks, they just want to stay beau-
tiful and maintain their sexuality, why should I stop them?’
Sanabria often heard gynecologists present HRT as a form of basic self-care. With
menopause, ‘the body’  one gynecologist told her  ‘begins to age and decay. Women
today live longer and stay sexually active. HRT just helps them keep up with their lives
and maintain their relationships.’ Implicit is the idea that a man  whose sexuality is nat-
uralized  is entirely justified to seek sex from younger women if his wife becomes lar-
gada (unkept).
Zunara is 61 and has always refused HRT. A lesbian, feminist and medical doctor, she
is outraged that hormo^nio is so prevalent in Brazilian gynecology. During a consultation,
her doctor expressed shock at how resecada (dry) Zunara’s vagina was and started to
instill fear in her, speaking of ‘a scorched field’ and risks of infection. Reflecting on the
event, she concluded that gynecologists who are ‘ferocious hormo^nio prescribers’ are
used to ‘nice pink vaginas’ and not to seeing ‘what a 61 year old vagina really looks like.’
The norm, by virtue of pharmaceutical intervention, has changed. It follows that 61-year
old vaginas are no longer, in private practice, ‘dry.’ What is a feminist response to this,
Zunara wondered? Promoting sexual pleasure beyond reproduction can be seen as part of
a project of sexual empowerment. However, this seems to be happening through the
imposition of a norm obliging women to remain sexually available and attractive accord-
ing to an idealized representation of (youthful) femininity. Women like Zunara who opt
out of HRT are considered ‘brave’, ‘alternative’ or irresponsible, and lacking in basic
self-care.
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Similarly, some plastic surgery patients described themselves or others as lacking suf-
ficient vaidade (vanity), which in Brazilian-Portuguese often has positive connotations.
Surgeons say plastica boosts self-esteem during menopause, presented as a difficult time
for women. Marcia, who had been waiting for ten months to have a second facelift, dis-
cussed plastica in relation to the lifecycle: ‘When I began menopause three years ago,
everything fell, fell really fast. Women age more quickly. . . menopause, hormones, breast
feeding, giving birth, everything deforms the stomach, your body. . . and domestic life too
is wear and tear, stress. And also men demand more of us.’ For Marcia plastica is a means
of compensating the damage due to physiological processes.
But Marcia’s commentary also points to changing gendered sexual expectations in
middle age. Brazilian aging norms have changed rapidly since the 1980s. As in much of
the industrialized world, Brazilian consumers have been ‘responsibilized’ for their health
as new ideals of ‘successful aging’ have been popularized in the media (Debert 2010;
Leibing 2005; Edmonds 2014). These norms include a striking focus on managing sexual
fitness and beauty. News media promote an ‘arsenal’ of medical and cosmetic practices
aimed at ‘sex after 40’: from sex toys and psychotherapy to testosterone-enhanced hor-
monal regimes and cosmetic surgery.
Marketing discourse, however, does not simply create ex-nihilo new medical needs, as
has been argued by some critics of medical enhancement. In this view, which resembles
critiques of irrational consumption, increasingly powerful medical institutions create new
market niches for previously unnecessary technologies. Yet hormo^nio and plastica have
been enthusiastically embraced partly because they ‘fit’ long-standing medical and social
realities; they have become, we suggest, integrated into familial and sexual life. In Brazil,
‘recreational’ or ‘plastic’ sexuality (Giddens 1993) coexists with ‘traditional’ forms of
patriarchal sexuality; sexually open youth cultures thrive alongside the dissemination of
the ‘modern’ norm of romantic, companionate marriage (Rebhun 1999; Mayblin 2010).
The men and women we met often saw sexual relationships as highly competitive
(Goldenberg 2010). While official justifications of plastic surgery often stress its psycho-
logical benefits, in intimate conversations concerns about maintaining relationships were
a major theme. Several women had undergone plastica following a break-up. One
recently divorced young mother received Sanabria in her home in her postoperative garter
for an interview on her use of menstrual suppressive implants. She explained that she had
always wanted to have plastica but that her ex-husband had not supported the idea; she
now wanted to show the world she could bounce back from a humiliating divorce.
Plastica and hormones are often used to maintain different types of relationships 
domestic, professional, class  in highly uncertain environments. Market niches for med-
ical technology coexist with what might be called social niches created by changing sex-
ual and gender norms and aspirations.
Paul Rabinow’s (1996) discussion of biosociality emphasizes the ‘horizontal’ rela-
tionships that form between people in shared genetic, risk or disease categories. It
emphasized how some patient groups have challenged older lay-expert relationships.
What this argument overlooks are the fracture lines in social groups formed around dis-
ease or risk, the places where the collective comes apart at the seams. In Brazil, elite
modes of medical consumption often become models for the popular classes. There is a
powerful aspirational dimension to entering the biosocial which is not always realized,
perhaps doomed by capitalist logics to remain incomplete. The bio in ‘biosociality’ is
thus also becoming  not something given or foundational to identity in the sense that
genetic or disease classifications are at times understood by Euro-American publics
(Strathern 1992).
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Conclusion
This paper has brought together materials from our respective research sites to explore
areas of clinical and social overlap in the uses of plastica and hormo^nio. While there are
important differences between these therapies, we have sought to show that together, they
are embroiled in redefinitions of normal femininity and caught up in complex class pro-
cesses. We have argued that they are used in highly experimental ways that blur the
boundaries between ‘well’ and ‘better than well.’
These uses have different  in a sense ‘inverted’  clinical logics. Sex hormones are
a ‘normal’ part of reproductive healthcare. Yet they are also used for medical and social
purposes that go beyond this indication: from travestis’ erotic body sculpting and men-
strual suppression to the aesthetic effects of the ‘beauty chip’ and sexual self-care. On the
other hand, cosmetic surgery is not ‘officially’ a part of reproductive healthcare. Yet it is
being integrated with obstetrics and gynecology, practiced in a public healthcare system,
and used to correct iatrogenic damage resulting from mainstream women’s healthcare.
As such it ‘borrows’ legitimacy from the clinical contexts in which it is practiced, as a
routine aspect of psychological, reproductive and sexual management. One result is that
‘aesthetics’ is emerging as a key dimension of women’s routine healthcare in Brazil
(Edmonds 2013a).
We aimed to expand the focus of a bioethics literature concerned with utopian or dys-
topian technologies to include their ordinary, everyday uses in Brazilian medical institu-
tions. This is an important critical task due to the sheer prevalence of the therapies we
discussed. With the growth of ‘drugs-for-pleasure’ (Race 2009), anabolic steroid use, rec-
reational Viagra, neuro-enhancement and other experimental means for boosting and cop-
ing, enhancement has become a crucial health and ethical issue ‘beyond the West.’ This
point is important as critiques of medical enhancement often assume that it spreads from
a Western ‘ground zero’ to other places. We argue that this timeline overlooks global
flows and feedback between regions. Brazilian experiments with sexual and aesthetic
medicine are ‘exported’ to richer, Western countries. Italian medical tourists travel to
Brazil for cosmetic surgery not because it is cheaper, but because it is more glamorous.
Brazilian doctors such as Elsimar Coutinho play a pivotal role in producing clinical
‘evidence’ in support of a global menstrual suppression discourse and off-label uses of
sex hormones.
These developments entail considerable risks.13 As technologies become embedded in
routine healthcare they also become more medically acceptable; health risks hence
become easier to minimize or dismiss. But these therapies are becoming routinized not
only because they have been aggressively or cynically marketed. Rather, they reveal con-
flicts in gendered norms concerning how to be properly and ideally desirable and desiring;
how to balance reproductive and sexual desires; and how to be a ‘good’ mother and a
‘modern’ woman.
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Notes
1. Our comparative analysis was not planned before we began fieldwork, but was initiated after
conversations where we perceived several important overlapping themes in our respective
research.
2. We use the term ‘therapy’ with implied quotation marks that we omit for simplicity: that is,
we do not imply surgery or sex hormones are always therapeutic.
3. Technologies used to deliver hormones have also changed significantly. The 21/7 regimen was
adopted to reproduce a monthly artificial bleeding episode that mimicked a ‘natural cycle’
(Marks 2001; Kissling 2013; Mamo & Fosket 2009). The stabilization of a normal 28-day
cycle was only later written into the design of the object itself (Sanabria 2009).
4. Elsimar Coutinho, controversial Bahian gynecologist and author of Is Menstruation Obsolete?
in whose clinic Sanabria carried out ethnographic work, claims to have discovered the con-
traceptive effects of medroxyprogesterone acetate (in Depo-Provera) and has developed a
range of hormonal implants in Brazil.
5. These occupy roughly 10% of the pharmaceutical market according to some estimates and can
be found in most shopping malls (Sanabria 2009).
6. Cosmetic procedures are also (legally) performed by doctors without training in plastic sur-
gery. One patient alleged that obstetricians had, in the 1980s, performed liposuction after
delivering a baby as a ‘favor’ to the patient (a claim surgeons dismissed).
7. http://boaforma.abril.com.br/famosas/famosas-em-boa-forma/carla-regina-emagreceu-5-
kg-532732.shtml (consulted 17 October 2013).
8. Roughly €1185.
9. ‘Reino das Formas Perfeitas,’ Epoca, 19 June 2000.
10. This campaign poster was brought to our attention by Silvia de Zordo.
11. Hormo^nio and plastica are often used to correct iatrogenic damage caused by other routine
medical technologies. Plastica is used to correct damage from mastectomy, previous plasti-
cas, as well as C-sections or assisted vaginal deliveries. Hormonal combination drugs that
have testosterone can optimize functioning harmed by other hormonal therapies or pharma-
ceuticals, or else replace endogenous hormones lost through hysterectomy.
12. This is not specific to Brazil, as attested to by the media hype surrounding Kate Middleton’s
exhibition of her flat and toned belly less than three months after giving birth to baby Prince
George.
13. For more discussion of these risks see Edmonds (2013a) and Sanabria (2010).
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